Potential for KY19382 on longitudinal growth (high iq debunkers gtfih)

birthdefect

birthdefect

Silver
Joined
Dec 24, 2025
Posts
543
Reputation
462
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit
 
  • +1
Reactions: Stacyslayerᛉ, Orka, Zagro and 1 other person
shits gonna get ignored like the last thread :feelsrope:
 
  • +1
Reactions: Stacyslayerᛉ, Orka and Zagro
Not worth it
 
  • +1
Reactions: childishkillah, Micrognathic, birthdefect and 1 other person
Just use AI + the price and efficiency ratio is bad
id imagine combining the 2 would be more effective than using just one. and its not that expensive if you can source it right, costs like a couple hundred for a years worth if you use it everyday and it increases chondrocyte proliferation while also delaying senescence
thank you for feedback bby :ogre:
 
  • +1
Reactions: Stacyslayerᛉ and Zagro
id imagine combining the 2 would be more effective than using just one. and its not that expensive if you can source it right, costs like a couple hundred for a years worth if you use it everyday and it increases chondrocyte proliferation while also delaying senescence
thank you for feedback bby :ogre:
I would need like 60mg daily for the translated human dose + considering the bioavailability changes in oral dosing, so even buying 1g for 200$ it lasts like 15 days
 
  • +1
Reactions: Micrognathic
bro what how big are you, how much do you weigh and how tall are you?
 
  • +1
Reactions: Stacyslayerᛉ
bro what how big are you, how much do you weigh and how tall are you?
66kg and you need to also consider that the oral bioavailability is like 10%-25% max
 
  • +1
Reactions: birthdefect, childishkillah, Stacyslayerᛉ and 1 other person
Yo, sorry I didn’t saw your last thread, was on vacation. Will read this thread later :feelsokman:
 
  • Love it
Reactions: birthdefect
66kg and you need to also consider that the oral bioavailability is like 10%-25% max
i guess ill be the labrat
im pretty sure that would be enough honestly, planning on taking it sublingually
 
  • +1
Reactions: Stacyslayerᛉ
disclaimer: this is my thread from .gg
again just gonna be a quick thread like the last one on combining ghrfs + gh

ky19382 is a small molecule indirubin analogue which acts primarily as an inhibitor of the protein-protein interaction between CXXC5 and Dishevelled (dvl), while simultaneously acting as a Glycogen Synthase Kinase 3 Beta(gsk3b) inhibitor. Through these actions, it acts as a potent canonical Wnt/Beta catenin upregulator. Originally used to treat alopecia through upregulation of the Wnt/B catenin pathway, it was found to also promote wound healing, and most importantly longitudinal growth in adolescent mice.

Hair growth: ky19382 was shown to be more effective than minoxidil in rats in one study, and was able to promote de novo follicle formation, as in the growth of completely new hair follicles in adult tissue, thought to have been impossible until the discovery of this and other Wnt and HH modulators/upregulators.

Wound Healing: ky19382 accelerates wound healing by around 30%-50%, and was significantly faster than using endothelial growth factor (EGF) and PTD-DBM, which is a peptide that targets the same pathway as ky19382 itself. PTD-DBM is most likely inferior to ky19382 due to not affecting gsk3b, a factor which when inhibited, promotes the accumulation of nuclear beta catenin, which is beneficial for all of ky19382's desired effects.

Longitudinal growth:
This is the real important part on why ky19382 is such a mogger compound.
I'm sure that basically everyone on here knows that estrogen fuses the plates. It does this through both genomic and non genomic signalling pathways, which I'm not going to get deep into. When estrogen binds to the estrogen receptor alpha (ErA), it dimerises into hetero or homo dimers and moves within the nucleus of the cell. These dimers bind to estrogen response elements (ERE) in the cxxc5 promoter region of the dna, leading to increased cxxc5 expression which acts as the direct tool to upregulate growth plate fusion. CXXC5 causes a decrease in nuclear beta catenin levels, which are necessary to promote proliferative genes such as Sox9. We know a lack of CXXC5 can prevent estrogen from inducing senescence, because in mice models where the gene of CXXC5 is knocked out, the plates can't close even in high estrogen environments.

From this, I'm sure you've gathered that CXXC5 inhibition is very downstream and likely smarter compared to the relatively caveman-brained method of just inhibiting aromatase to slow bone age. But, does this mean its enough?

Is aromatase inhibition still needed?

From the studies with CXXC5 knockout models, we know that even if CXXC5 is missing and the plates cant fuse, estrogen genomic signalling still occurs as the receptor can bind to other genes. This means that even though your chondrocytes will keep proliferating and hypertrophying, your chondrocytes will still "age", in the sense that as they continue to multiply, they will retain the genomic changes made by estrogen, maturing and dying faster than they would have otherwise. Using ky19382 would likely allow for estrogen levels to be higher than actually needed to delay fusion, but you might still need to use low dose aromatase inhibitors (i recommend arimidex). I genuinely believe that aromatase inhibition combined with cxxc5 - dvl inhibition could potentially add 3+ years of active growth plate chondrocyte proliferation, hypertrophy, and thus growth.

Can more be done?

I'm sure most of you have heard of HDACi to promote longitudinal growth, unfortunately the reasoning behind it is pretty shit and pan-hdaci such as vorinostat are known to have a detrimental impact on growth. A lot of hdacs are necessary for longitudinal growth to occur, and one of high interest is HDAC4. HDAC4 is a crucial downstream factor to prevent chondrocytes from beginning to hypertrophy. Theoretically, if HDAC4 was upregulated, aromatase was inhibited, and cxxc5 - dvl interaction was inhibited, the growth plate may never fuse, allowing us to use androgens and hgh for pretty much as long as we need. I'm not going to get into how HDAC4 could be increased in the growth plate (likely gonna gatekeep further information on exact compounds needed), but the potential is there.

How would KY19382 actually be used?

A benefit of using small molecules over most other compounds is oral bioavailability, which ky19382 favourably exhibits. From some studies ive read (and just asking google's ai :forcedsmile:) the best easily available solvent for it is peg400 at around a 60%-80% mix with water (probably distilled or purified or whatever). Buying it from a mainstream source is genuinely expensive as fuck, on medchem express 100mg costs like 2k usd. Comparatively, from my source ky19382 costs around the same but for 10 grams, which lasts way way longer. To convert rat oral dosing to human dosing you have to determine human equivalent dose, which im not fucked explaining. Just ask ai to do it
sorry for the giga low effort thread i wasnt bothered finding pictures, if i got anything wrong please correct me cus this is all from memory

tagging high iq niggas
@Zagro @Stacyslayerᛉ @Sachlichkeit
ya

but WNTB pathway activation via KY19382 at human adjusted doses low reward high risk. At adjusted doses the cancer risk is massive correct me if im wrong.

Between theory and practical application you want to steer clear of research chemicals and lean on FDA approved drugs if you actually intend on using these things. I have bottle of oral self compounded KY in fridge rn, grew my hair out nice, thats about it. dosages were v and adjusted from anecdotal account of old poster who (apparently,) injected it. also muscle soreness.

ROMO is only FDA approved WNTB cantenin modulator, and has little effect on plates

TGFB transforming growth factor beta is more important for bone growth than WNTB though there is no drug available

if u want real edge on .org "competition" find out what the medical standard for X or Y is and then use that, because billions of dollars and hours have been poured into things you are probably researching.

I could say deca is the best steroid for bones, but some oldhead probably 30 years ago said the same thing, ran the studies, wasted bunch of time and money only to find out that testosterone is better risk reward for X or Y reason.

If "pfizer" could make a better androgen than testosterone, patent it, then market it as "TRT" they would because they would make billions, but they haven't.

The osteoporotic drugs are,
Romosozumab
PTH analogs
Biphosphonates
 
ya

but WNTB pathway activation via KY19382 at human adjusted doses low reward high risk. At adjusted doses the cancer risk is massive correct me if im wrong.

Between theory and practical application you want to steer clear of research chemicals and lean on FDA approved drugs if you actually intend on using these things. I have bottle of oral self compounded KY in fridge rn, grew my hair out nice, thats about it. dosages were v and adjusted from anecdotal account of old poster who (apparently,) injected it. also muscle soreness.

ROMO is only FDA approved WNTB cantenin modulator, and has little effect on plates

TGFB transforming growth factor beta is more important for bone growth than WNTB though there is no drug available

if u want real edge on .org "competition" find out what the medical standard for X or Y is and then use that, because billions of dollars and hours have been poured into things you are probably researching.

I could say deca is the best steroid for bones, but some oldhead probably 30 years ago said the same thing, ran the studies, wasted bunch of time and money only to find out that testosterone is better risk reward for X or Y reason.

If "pfizer" could make a better androgen than testosterone, patent it, then market it as "TRT" they would because they would make billions, but they haven't.

The osteoporotic drugs are,
Romosozumab
PTH analogs
Biphosphonates
why focus on bone over chondrocytes for height? although pthrp analogues do have the potential to keep the chondrocytes younger

would cancer risk between gh and ky19382 be similar or nah? as far as i know ky19382 restores wnt signalling rather thsn just upregulating it, and in certain cancers its shown to actuslly downregulate wnt. from memory tho could be wrong
 
Last edited:

Similar threads

birthdefect
Replies
9
Views
107
maxismisha
maxismisha
EMS-AF
Replies
15
Views
410
Flowix
F
S
Replies
12
Views
734
Tjan
Tjan
E
Replies
10
Views
785
Etson
Etson

Users who are viewing this thread

Back
Top